Introduction Patent portfolios are critical assets for pharmaceutical companies, providing market exclusivity and protecting revenue streams for drug products. Effective management of drug patent portfolios requires strategic planning, ongoing evaluati…
Best Practices for Drug Patent Portfolio Management Read Post »
Excipients, the inactive substances used in drug formulations, play a crucial role in the stability, bioavailability, and overall effectiveness of medications. However, they can also be a source of adverse side effects, ranging from mild intolerances t…
Biotechnology plays a crucial role in developing new and improved vaccines through several innovative approaches: These biotechnological advancements have significantly
Biotechnology and the Microbiome: Exploring New Horizons Read Post »
In the ever-evolving pharmaceutical landscape, the art of tablet formulation is a delicate dance between active ingredients and excipients. Excipients, often referred to as the unsung heroes of drug development, play a pivotal role in ensuring the effi…
Optimizing Tablet Formulations: The Crucial Role of Excipient Selection Read Post »
The biotechnology sector continues to be a dynamic and rapidly evolving field, with companies pushing the boundaries of science and
Top Biotechnology Companies Leading the Way in 2024 Read Post »
Annual Drug Patent Expirations for IGALMI Igalmi is a drug marketed by Bioxcel and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug. This drug has sixty-five patent family members in sixteen countr…
Annual Drug Patent Expirations for PHEXXI Phexxi is a drug marketed by Evofem Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. PHEXXI drug price trends. This drug has sixty-four patent fami…
Annual Drug Patent Expirations for PHEXXI Phexxi is a drug marketed by Evofem Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. PHEXXI drug price trends. This drug has sixty-four patent fami…
Annual Drug Patent Expirations for JULUCA Juluca is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. JULUCA drug price trends. Drug patent litigation for JULUCA…
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs. There are three patents protecting this compound. Drug pat…
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
Get new actionable insights and updates from BiotechBlog
